Article
BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumors
24 Jun 2019
Abstract excerpt
Although discussed using variable terminology, cutaneous BRCA1-associated protein (BAP1)-inactivated melanocytic tumor (BIMT) has been considered a discrete diagnostic entity since 2011. Here, we review the initial genomic studies that identified these distinct melanocytic tumors and the clinical and histopathological features that define these tumors. These epithelioid, predominantly dermal, and melanocytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
